Literature DB >> 15837127

Coherent spike-wave oscillations in the cortex and subthalamic nucleus of the freely moving rat.

P J Magill1, A Sharott, D Harnack, A Kupsch, W Meissner, P Brown.   

Abstract

The basal ganglia play a critical role in controlling seizures in animal models of idiopathic non-convulsive (absence) epilepsy. Inappropriate output from the substantia nigra pars reticulata (SNr) is known to exacerbate seizures, but the precise neuronal mechanisms underlying abnormal activity in SNr remain unclear. To test the hypothesis that cortical spike-wave oscillations, often considered indicative of absence seizures, propagate to the subthalamic nucleus, an important afferent of SNr, we simultaneously recorded local field potentials from the frontal cortex and subthalamic nucleus of freely moving rats. Spontaneous spike-wave oscillations in cortex (mean dominant frequency of 7.4 Hz) were associated with similar oscillations in the subthalamic nucleus (mean of 7.9 Hz). The power of oscillations at 5-9 Hz was significantly higher during spike-wave activity as compared with rest periods without this activity. Importantly, spike-wave oscillations in cortex and subthalamic nucleus were significantly coherent across a range of frequencies (3-40 Hz), and the dominant (7-8 Hz) oscillatory activity in the subthalamic nucleus typically followed that in cortex with a small time lag (mean of 2.7 ms). In conclusion, these data suggest that ensembles of subthalamic nucleus neurons are rapidly recruited into oscillations during cortical spike-wave activity, thus adding further weight to the importance of the subthalamic nucleus in absence epilepsy. An increase in synchronous oscillatory input from the subthalamic nucleus could thus partly underlie the expression of pathological activity in SNr that could, in turn, aggravate seizures. Finally, these findings also reiterate the importance of oscillations in these circuits in normal behaviour.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837127     DOI: 10.1016/j.neuroscience.2005.01.006

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Elevation of GABA levels in the globus pallidus disinhibits the thalamic reticular nucleus and desynchronized cortical beta oscillations.

Authors:  Nelson Villalobos; Salvador Almazán-Alvarado; Victor Manuel Magdaleno-Madrigal
Journal:  J Physiol Sci       Date:  2022-07-27       Impact factor: 2.257

2.  Functional definition of seizure provides new insight into post-traumatic epileptogenesis.

Authors:  Raimondo D'Ambrosio; Shahin Hakimian; Tessandra Stewart; Derek R Verley; Jason S Fender; Clifford L Eastman; Aaron H Sheerin; Puneet Gupta; Ramon Diaz-Arrastia; Jeffrey Ojemann; John W Miller
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

3.  5-HT2C and GABAB receptors influence handling-induced convulsion severity in chromosome 4 congenic and DBA/2J background strain mice.

Authors:  Matthew T Reilly; Lauren C Milner; Renee L Shirley; John C Crabbe; Kari J Buck
Journal:  Brain Res       Date:  2008-01-18       Impact factor: 3.252

4.  Characterizing the spiking dynamics of subthalamic nucleus neurons in Parkinson's disease using generalized linear models.

Authors:  Uri T Eden; John T Gale; Ramin Amirnovin; Emad N Eskandar
Journal:  Front Integr Neurosci       Date:  2012-06-20

5.  Low and High Gamma Oscillations in Rat Ventral Striatum have Distinct Relationships to Behavior, Reward, and Spiking Activity on a Learned Spatial Decision Task.

Authors:  Matthijs A A van der Meer; A David Redish
Journal:  Front Integr Neurosci       Date:  2009-06-11

6.  Systemic blockade of dopamine D2-like receptors increases high-voltage spindles in the globus pallidus and motor cortex of freely moving rats.

Authors:  Chen Yang; Shun-Nan Ge; Jia-Rui Zhang; Lei Chen; Zhi-Qiang Yan; Li-Jun Heng; Tian-Zhi Zhao; Wei-Xin Li; Dong Jia; Jun-Ling Zhu; Guo-Dong Gao
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.